EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli

Szabolcs Semsey, Emilie Søndberg, Mathilde Røen, Björn Hallström, Anders Østergaard Petersen, Lauge Alfastsen, Berta Rosich Bosch, Benjamin Wohl, Jasper Clube, Eric van der Helm, Christian Groendahl, Ioannis Mougiakos iD

Nucleic Acids Research · 26.11.2025 · 53 (22)

DOI: 10.1093/nar/gkaf1394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.12.2025. Verfasst von Szabolcs Semsey und 11 weiteren Autor:innen. Beteiligte Einrichtung: SNIPR Biome ApS, 2100, Copenhagen, Denmark. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Escherichia coli, Gene Editing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SNIPR Biome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR–Cas systems have revolutionized genome engineering technologies, but type IV CRISPR–Cas systems and their genome engineering potential have been critically underexplored. In this study, we identified a type IV-A3 CRISPR–Cas system from a clinical Klebsiella pneumoniae isolate and characterized its plasmid targeting activity and capacity to suppress chromosomal and plasmid gene expression in Escherichia coli. We revealed the pivotal role of Csf3 (Cas5) and the dispensable roles of Csf1 (Cas8-like) and Csf4 (DinG helicase) subunits in IV-A3 CRISPR–Cas complex formation. The system prevents plasmid propagation via interplay between DinG helicase activity and strategic protospacer positioning relative to plasmid replication and maintenance components. We enabled the IV-A3 CRISPR–Cas system to introduce lethal, sequence-specific double-stranded (ds)DNA breaks in the E. coli chromosome by fusing the nuclease domain of the I-TevI nuclease to the Cas8 N-terminus. Further, we developed a series of base editors, with various editing efficiencies and windows, by fusing the PmCDA1 cytidine deaminase to the Cas8, Cas5, and DinG subunits. Finally, conjugative transfer of the Cas5–PmCDA1 base editor into E. coli deactivated the tryptophan repressor gene, boosting IAA production. Our study provides new insights into type IV-A3 CRISPR–Cas systems and highlights their potential in genome engineering applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsEscherichia coliGene EditingPlasmidsKlebsiella pneumoniaeGenome, BacterialDNA HelicasesBacterial Proteins

Substanzen

DNA HelicasesBacterial Proteins

Autor:innen und Institutionen

  • SNIPR Biome ApS, 2100, Copenhagen, Denmark.

ORCID-Profile: Ioannis Mougiakos

Förderung

  • SNIPR Biome

Zitieren

APA

Semsey, S., Søndberg, E., Røen, M., Hallström, B., Petersen, A. Ø., Alfastsen, L., Bosch, B. R., Wohl, B., Clube, J., van der Helm, E., Groendahl, C., & Mougiakos, I. (2025). Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli. Nucleic Acids Research, 53(22). https://doi.org/10.1093/nar/gkaf1394

Vancouver

Semsey S, Søndberg E, Røen M, Hallström B, Petersen AØ, Alfastsen L, et al. Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli. Nucleic Acids Research. 2025;53(22). doi:10.1093/nar/gkaf1394

BibTeX
@article{Semsey2025,
  author = {Semsey, Szabolcs and Søndberg, Emilie and Røen, Mathilde and Hallström, Björn and Petersen, Anders Østergaard and Alfastsen, Lauge and Bosch, Berta Rosich and Wohl, Benjamin and Clube, Jasper and van der Helm, Eric and Groendahl, Christian and Mougiakos, Ioannis},
  title = {Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {22},
  doi = {10.1093/nar/gkaf1394}
}
Kostenlos starten →